ARRIVENT BIOPHARMA IN
28.80
26-November-24 15:43:42
15 minutes delayed
Stocks
+1.30
+4.73%
Today's range
27.15 - 29.16
ISIN
N/A
Source
NASDAQ
-
ArriVent BioPharma Reports Third Quarter 2024 Financial Results
14 Nov 2024 08:00:00 By Nasdaq GlobeNewswire
-
ArriVent BioPharma Reports Second Quarter 2024 Financial Results
14 Aug 2024 16:01:00 By Nasdaq GlobeNewswire
-
12 Aug 2024 08:00:00 By Nasdaq GlobeNewswire
-
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
05 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
16 May 2024 16:05:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >